Back to top

Madrigal Pharmaceuticals (MDGL) Receives a Buy from Jefferies

In a report released today, from Jefferies maintained a Buy rating on Madrigal Pharmaceuticals, with a price target of $600.00. In addition to Jeff...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Madrigal Pharmaceuticals, Inc. (MDGL)